SCHEMBL20925147

SCHEMBL20925147

N#Cc1c(-n2c3ccccc3c3ccc(C(F)(F)F)cc32)cc(-c2ccc(C(F)(F)F)cc2C(F)(F)F)cc1-n1c2ccccc2c2ccc(C(F)(F)F)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.43
AR P10275 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MAT2A P31153 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2C9 P11712 1/20 0.33
SCN9A Q15858 1/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
KDM4E B2RXH2 3/20 0.32
GAA P10253 2/20 0.32
HPGD P15428 2/20 0.32
HSP90AA1 P07900 1/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111819 0.97 KIF11 (0.40) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL20111559 0.96 KIF11 (0.39) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL20111864 0.95 KIF11 (0.42) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL20111868 0.95 KIF11 (0.38) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL21258795 0.95 KIF11 (0.38) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL20925150 0.94 KIF11 (0.36) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL21258688 0.94 KIF11 (0.38) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL25659200 0.94 KIF11 (0.40) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL20925149 0.93 KIF11 (0.38) KIF11ARMEN1KMT2AALDH1A1
SCHEMBL20111865 0.93 KIF11 (0.39) KIF11ARMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10971688-B2 Organic molecules for use in organic optoelectronic devices CYNORA GMBH (DE) 2021-04-06 US disclosed
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-15 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10971688-B2 Organic molecules for use in organic optoelectronic devices OR10J3, OR51E2, OPRM1 KIF11 3426/4885AR 4611/4885MEN1 3321/4885
US-20190248741-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 KIF11 3661/4885AR 4386/4885MEN1 3287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.